Customer Guest
Register|Generate Password
For Login related queries e-mail: emkayassist@emkayglobal.com
Get world class research developed by an in house team of professionals backed with strong institutional support. With reports that span across time horizons, styles and easily actionable strategies, you are never too far from executing a winning trade.
Login | Register
Login | Register|Forgot password?
RBI maintains status quo on rates on inflationary concern. However, a host of unconventional measures were taken to incentivize the transmission of earlier rate cuts amid significant systemic liquidity.
Broad-based stabilization in top-line growth but overall numbers still weak: With nearly half of the stocks under our coverage having reported Q3FY20 results, we take stock of the earnings season so far.
Tier-I techs continued to see a moderation in revenue growth in Dec’19 quarter. The sole exception was TechM which benefitted from a strong uplift in the Communications vertical.
Wholesales are expected to be under pressure across segments in March due to lockdowns in...
Read-through from Accenture’s Q2FY20 (FY ending Aug’20) results for Indian IT: Possible d...
Peaking of Covid-19 count in the West could be key milestone for market sentiment: While...
The Government has come up with an ambitious plan of spending Rs102tn to boost the infras...
Recent underperformance and improving margin outlook on easing input prices provide a goo...
Q3FY20 revenues declined 5% yoy (our est.: down 2%) for companies under our coverage, exc...
EBITDA loss of $54/t in the Europe business was significantly higher than our est. of $25...
Shoppers Stop reported in-line operating performance, with 1% SSSG and comparable EBITDA...
Reliance Industries (RIL) reported consolidated EBITDA of Rs223.9bn in Q3FY20, up 5% yoy, 1% qoq and in line with our estimate.
Despite lower NIMs and higher LLP provisions (~130bps), HDFCB reported PAT beat at Rs74bn (up 33% yoy), mainly helped by strong fees and NPA recovery.
TCS’s Dec’19 quarter results continued the trend of revenue growth moderation that has sustained in YTD FY20.
The S&P500 Index delivered a 29% return in 2019. In the last 91 years, the S&P500 Index has given more than 28% returns in a calendar year only 10 times, i.e., only 11% of the time period.
Ajanta Pharma announced a Rs 1bn share buyback on 30th January 2019. The buyback of up to 0.8mn shares represents 0.9% of the total number...
MSCI proposes changes to Foreign ownership Investment limits for India Securities. On April 5, 2018 the Securities and Exchange Board of India (SEBI)...